From Regulation To Innovation: How ICH Oversight Changes And AI Are Shaping The Future Of Clinical Trials

New ICH revisions are redefining what effective trial oversight looks like, placing new emphasis on transparency, proactive risk management, and operational accountability. In this session, we’ll unpack what these changes mean for sponsors and the wider industry and highlight the most urgent oversight priorities now emerging. We will then explore how artificial intelligence is reshaping oversight—through predictive insights, automated analytics, and unified platforms like the Clinical Decision Suite—to help sponsors not only meet evolving compliance expectations but also drive smarter, more efficient trial delivery.

Key Learning Objectives: 

• Gain insights into the recently released ICH E6 (R3) revisions and their implications for clinical trial oversight
• Assess strategies for sponsors to adapt to changing compliance requirements and enhance trial management
• Discover how artificial intelligence is transforming clinical trial oversight with predictive insights, automated analytics, and integrated platforms like the Clinical Decision Suite